Mersana Therapeutics Inc (MRSN) Technical Analysis
$10.70▲3.88%
Market is closed - opens 7 PM, 16 Oct 2025
Insights
- Mersana Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Mersana Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Mersana Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Mersana Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 75.84 | Sell |
Stochastic | 99.39, 92.08 | Neutral |
Ultimate Oscillator | 75.8 | Sell |
Stochastic Relative Strength Index | 92.57, 86.98 | Neutral |
Moving Average Convergence Divergence | 0.62, 0.36 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 8.83 | Buy |
20 | 8.12 | Buy |
50 | 7.54 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.02 | Buy |
20 | 8.44 | Buy |
50 | 7.98 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.01 | Buy |
20 | 8.39 | Buy |
50 | 7.56 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.8 | Buy |
20 | 9.18 | Buy |
50 | 8.1 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 10.11 | Buy |
20 | 9.68 | Buy |
50 | 8.64 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 11.49 |
Resistance L2 | 10.9 |
Resistance L1 | 10.41 |
Pivot Point | 9.82 |
Support L1 | 9.33 |
Support L2 | 8.74 |
Support L3 | 8.25 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.